Prestige Consumer Healthcare (PBH)
NYSE:PBH
Want to see PBH full AI Analyst Report?
Total Valuation
Prestige Consumer Healthcare has a market cap or net worth of $2.24B. The enterprise value is $3.22B.
Market Cap$2.24B
Enterprise Value$3.22B
Share Statistics
Prestige Consumer Healthcare has 47,372,166 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,372,166
Owned by Insiders1.41%
Owned by Institutions10.23%
Financial Efficiency
Prestige Consumer Healthcare’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.65%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.65%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee1.81M
Profits Per Employee317.17K
Employee Count600
Asset Turnover0.31
Inventory Turnover3.23
Valuation Ratios
The current PE Ratio of Prestige Consumer Healthcare is 15.1. Prestige Consumer Healthcare’s PEG ratio is -1.67.
PE Ratio15.1
PS Ratio2.64
PB Ratio1.52
Price to Fair Value1.52
Price to FCF11.30
Price to Operating Cash Flow8.43
PEG Ratio-1.67
Income Statement
In the last 12 months, Prestige Consumer Healthcare had revenue of 1.09B and earned 190.30M in profits. Earnings per share was 3.93.
Revenue1.09B
Gross Profit574.64M
Operating Income309.41M
Pretax Income257.50M
Net Income190.30M
EBITDA340.68M
Earnings Per Share (EPS)3.93
Cash Flow
In the last 12 months, operating cash flow was 265.41M and capital expenditures -11.18M, giving a free cash flow of 254.23M billion.
Operating Cash Flow265.41M
Free Cash Flow254.23M
Free Cash Flow per Share5.37
Dividends & Yields
Prestige Consumer Healthcare pays an annual dividend of $0.475, resulting in a dividend yield of ―
Dividend Per Share$0.475
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.35
52-Week Price Change-44.10%
50-Day Moving Average56.51
200-Day Moving Average62.00
Relative Strength Index (RSI)30.25
Average Volume (3m)456.76K
Important Dates
Prestige Consumer Healthcare upcoming earnings date is Jul 30, 2026, Before Open (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Prestige Consumer Healthcare as a current ratio of 3.57, with Debt / Equity ratio of 55.39%
Current Ratio3.57
Quick Ratio2.25
Debt to Market Cap0.35
Net Debt to EBITDA2.88
Interest Coverage Ratio7.31
Taxes
In the past 12 months, Prestige Consumer Healthcare has paid 67.19M in taxes.
Income Tax67.19M
Effective Tax Rate0.26
Enterprise Valuation
Prestige Consumer Healthcare EV to EBITDA ratio is 11.31, with an EV/FCF ratio of 15.16.
EV to Sales3.54
EV to EBITDA11.31
EV to Free Cash Flow15.16
EV to Operating Cash Flow14.52
Balance Sheet
Prestige Consumer Healthcare has $63.87M in cash and marketable securities with $1.05B in debt, giving a net cash position of -$981.56M billion.
Cash & Marketable Securities$63.87M
Total Debt$1.05B
Net Cash-$981.56M
Net Cash Per Share-$20.72
Tangible Book Value Per Share-$20.50
Margins
Gross margin is 53.96%, with operating margin of 28.42%, and net profit margin of 17.48%.
Gross Margin53.96%
Operating Margin28.42%
Pretax Margin23.65%
Net Profit Margin17.48%
EBITDA Margin31.29%
EBIT Margin28.42%
Analyst Forecast
The average price target for Prestige Consumer Healthcare is $82.94, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$82.94
Price Target Upside42.67% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast-4.31%
EPS Growth Forecast-8.94%